- Type / Class
- Equity / Common Stock
- Shares outstanding
- 131,352,709
- Total 13F shares
- 51,432,581
- Share change
- +1,583,520
- Total reported value
- $1,119,137,255
- Price per share
- $21.76
- Number of holders
- 103
- Value change
- +$31,274,087
- Number of buys
- 70
- Number of sells
- 24
Quarterly Holders Quick Answers
What is CUSIP 92243G108?
CUSIP 92243G108 identifies PCVX - Vaxcyte, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92243G108:
Top shareholders of PCVX - Vaxcyte, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
6.4%
|
8,376,942
|
$202,304,000 | — | 31 Mar 2022 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
3.5%
|
4,581,203
|
$110,636,000 | — | 31 Mar 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
3.3%
|
4,329,764
|
$104,556,000 | — | 31 Mar 2022 | |
| Abingworth LLP |
13F
|
Company |
3.2%
|
4,168,718
|
$100,508,000 | — | 31 Mar 2022 | |
| TPG GP A, LLC |
13F
|
Company |
3.1%
|
4,055,092
|
$97,930,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.8%
|
3,629,364
|
$87,649,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.2%
|
2,886,022
|
$69,698,000 | — | 31 Mar 2022 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.8%
|
2,309,554
|
$55,776,000 | — | 31 Mar 2022 | |
| Medicxi Ventures Management (Jersey) Ltd |
13F
|
Company |
1.4%
|
1,887,478
|
$45,582,000 | — | 31 Mar 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.2%
|
1,513,659
|
$36,555,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
1,384,168
|
$33,428,000 | — | 31 Mar 2022 | |
| EcoR1 Capital, LLC |
13F
|
Company |
0.99%
|
1,304,741
|
$31,509,000 | — | 31 Mar 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.87%
|
1,144,815
|
$27,648,000 | — | 31 Mar 2022 | |
| Pivotal bioVenture Partners Investment Advisor LLC |
13F
|
Company |
0.85%
|
1,111,485
|
$26,842,000 | — | 31 Mar 2022 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
0.67%
|
885,153
|
$21,376,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.55%
|
721,963
|
$17,435,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.55%
|
717,955
|
$17,339,000 | — | 31 Mar 2022 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.44%
|
579,640
|
$13,998,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.29%
|
382,125
|
$9,228,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.26%
|
342,551
|
$8,273,000 | — | 31 Mar 2022 | |
| Soleus Capital Management, L.P. |
13F
|
Company |
0.25%
|
328,350
|
$7,930,000 | — | 31 Mar 2022 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.24%
|
315,991
|
$7,630,000 | — | 31 Mar 2022 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.23%
|
300,000
|
$7,245,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.2%
|
262,720
|
$6,345,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.2%
|
262,291
|
$6,335,000 | — | 31 Mar 2022 | |
| Opaleye Management Inc. |
13F
|
Company |
0.16%
|
211,000
|
$5,096,000 | — | 31 Mar 2022 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.16%
|
207,240
|
$5,005,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.12%
|
152,364
|
$3,680,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.11%
|
140,826
|
$3,483,000 | — | 31 Mar 2022 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.07%
|
90,000
|
$2,174,000 | — | 31 Mar 2022 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.07%
|
89,010
|
$2,150,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.07%
|
88,924
|
$2,148,000 | — | 31 Mar 2022 | |
| Walleye Capital LLC |
13F
|
Company |
0.05%
|
69,452
|
$1,677,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.05%
|
60,387
|
$1,458,000 | — | 31 Mar 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.04%
|
58,048
|
$1,402,000 | — | 31 Mar 2022 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.04%
|
52,100
|
$1,258,000 | — | 31 Mar 2022 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
50,789
|
$1,227,000 | — | 31 Mar 2022 | |
| Swiss National Bank |
13F
|
Company |
0.04%
|
50,000
|
$1,208,000 | — | 31 Mar 2022 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
49,800
|
$1,202,000 | — | 31 Mar 2022 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.03%
|
44,000
|
$1,063,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.03%
|
40,800
|
$985,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.03%
|
38,477
|
$929,000 | — | 31 Mar 2022 | |
| BROWN BROTHERS HARRIMAN & CO |
13F
|
Company |
0.03%
|
38,033
|
$918,000 | — | 31 Mar 2022 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
36,314
|
$877,000 | — | 31 Mar 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.03%
|
35,900
|
$867,000 | — | 31 Mar 2022 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.02%
|
30,656
|
$740,000 | — | 31 Mar 2022 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
30,369
|
$733,000 | — | 31 Mar 2022 | |
| Temasek Holdings (Private) Ltd |
13F
|
Company |
0.02%
|
27,272
|
$658,619 | — | 31 Mar 2022 | |
| Invesco Ltd. |
13F
|
Company |
0.02%
|
27,189
|
$656,000 | — | 31 Mar 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
26,792
|
$647,000 | — | 31 Mar 2022 |
Institutional Holders of Vaxcyte, Inc. - Common Stock (PCVX) as of Q2 2022
As of 30 Jun 2022,
Vaxcyte, Inc. - Common Stock (PCVX) was held by
103 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,432,581 shares.
The largest 10 holders included
FMR LLC, RA CAPITAL MANAGEMENT, L.P., JANUS HENDERSON GROUP PLC, Abingworth LLP, VANGUARD GROUP INC, TPG GP A, LLC, BlackRock Inc., Medicxi Ventures Management (Jersey) Ltd, STATE STREET CORP, and Frazier Life Sciences Management, L.P..
This page lists
103
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
86
Q2 2022 holders
103
Holder diff
17
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.